3.6 GLP-1 RAs in clinical practice The cardioprotective properties of GLP-1 RAs seem to be mediated through CV risk factors modification
12 , 18 , 21 , 24 It is also important to acknowledge that the influence of other unrecognized or under-reported GI motility disorders may have been underestimated in the included populations
Schmitt A, Reimer A, Hermanns N, Kulzer B, Ehrmann D, Krichbaum M, et al
Always seek advice from a healthcare professional before starting or changing any treatment for side effects
Mitochondrial complex II is a source of the reserve respiratory capacity that is regulated by metabolic sensors and promotes cell survival
Long-term sustainability on a minimal dose also requires addressing the underlying drivers of your weight gain